Genapsys Stock
GenapSys develops DNA sequencing technologies and systems for applied genomic testing and medical sequencing.
About Genapsys Stock
GenapSys, Inc. is committed to a new era of applied genomic testing and a new paradigm for medical sequencing. We are developing a cost-disruptive, easy-to-use genomic diagnostic system based on our simple label-free proprietary GENIUS™ technology which delivers 100x improvement in cost and speed. These innovations will enable a new era of medicine through the widespread acquisition of genomic data for research and testing of genetic disease, cancer, and microbes.
Funding History
| May 2012 | $0 |
|---|---|
| March 2013 | $8.5M |
| November 2013 | $37.0M |
Management
Head of Talent & Happiness
Diana Kofman
Director of Nanofabrication
Kosar Parizi
Director of Business Development
Avaleigh Milne
Senior Director & Head of Europe
Leila Zegna
Director of Sequencing
Xavier Gomes
Leads Strategic Initiatives
Howard Goldstein
VP of Product Development
Subra Sankar
VP Engineering
Hamid Rategh
Director of Product & Test Engineering
Ashok Ramachandran
Director of Chemistry
Aldrich Lau
Press
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Genapsys or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
